Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis
Jeremy Katzen, … , Robin R. Deterding, Michael F. Beers
Jeremy Katzen, … , Robin R. Deterding, Michael F. Beers
Published February 5, 2019
Citation Information: JCI Insight. 2019;4(6):e126125. https://doi.org/10.1172/jci.insight.126125.
View: Text | PDF
Research Article Pulmonology

An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis

  • Text
  • PDF
Abstract

Alveolar type 2 (AT2) cell endoplasmic reticulum (ER) stress is a prominent feature in adult and pediatric interstitial lung disease (ILD and ChILD), but in vivo models linking AT2 cell ER stress to ILD have been elusive. Based on a clinical ChILD case, we identified a critical cysteine residue in the surfactant protein C gene (SFTPC) BRICHOS domain whose mutation induced ER stress in vitro. To model this in vivo, we generated a knockin mouse model expressing a cysteine-to-glycine substitution at codon 121 (C121G) in the Sftpc gene. SftpcC121G expression during fetal development resulted in a toxic gain-of-function causing fatal postnatal respiratory failure from disrupted lung morphogenesis. Induced SftpcC121G expression in adult mice resulted in an ER-retained pro-protein causing AT2 cell ER stress. SftpcC121G AT2 cells were a source of cytokines expressed in concert with development of polycellular alveolitis. These cytokines were subsequently found in a high-dimensional proteomic screen of bronchoalveolar lavage fluid from ChILD patients with the same class of SFTPC mutations. Following alveolitis resolution, SftpcC121G mice developed spontaneous pulmonary fibrosis and restrictive lung impairment. This model provides proof of concept linking AT2 cell ER stress to fibrotic lung disease coupled with translationally relevant biomarkers.

Authors

Jeremy Katzen, Brandie D. Wagner, Alessandro Venosa, Meghan Kopp, Yaniv Tomer, Scott J. Russo, Alvis C. Headen, Maria C. Basil, James M. Stark, Surafel Mulugeta, Robin R. Deterding, Michael F. Beers

×

Figure 5

Expression of mutant SftpcC121G causes lung injury with polycellular alveolitis.

Options: View larger image (or click on image) Download as PowerPoint
Expression of mutant SftpcC121G causes lung injury with polycellular alv...
(A) Weight loss curve in surviving SftpcC121G/C121G R26Cre mice and SftpcWT R26Cre controls treated with tamoxifen. *P < 0.05 vs. control group using unpaired 2-tailed t test. (B) Kaplan-Meier survival curve of SftpcC121G/C121G R26Cre mice treated with tamoxifen (n = 43) or vehicle (oil) (n = 16) and SftpcWT R26Cre mice treated with tamoxifen (n = 32). End points were defined as death or body weight <75% on 2 consecutive days. P < 0.001 by log-rank (Mantel-Cox) test. (C) Pulse oximetry of SftpcC121G/C121G R26Cre mice and controls 7 days after tamoxifen. *P < 0.05 vs. control using unpaired 2-tailed t test. (D) BALF protein content following tamoxifen. Controls represent pooled samples from all 4 time points. *P < 0.05 by 1-way ANOVA with post hoc Tukey’s test. (E) Representative ×10 magnification H&E histology at 14 days after tamoxifen. Scale bars: 500 μm. (F) Dot plots with mean and SEM of BALF cell count following tamoxifen. Controls represent pooled samples from all 4 time points. *P < 0.05 by 1-way ANOVA with post hoc Tukey’s test. (G) Representative Giemsa-stained BALF cytospins from control and SftpcC121G/C121G R26Cre mice after tamoxifen (magnification, ×20). (H) Dot plots with mean and SEM of percentage of total lung digest immune cells (CD45+) that were alveolar macrophages (SiglecF+CD11b–) at 3 days after tamoxifen. *P < 0.05 vs. control using unpaired 2-tailed t test. (I) Representative control and SftpcC121G/C121G R26Cre flow cytometry gating for CD11b+Ly6Chi monocytes at day 3 after tamoxifen (left). Dot plots with mean and SEM of percentage of total lung digest immune cells (CD45+) that were CD11b+Ly6Chi monocytes. *P < 0.05 vs. control using unpaired 2-tailed t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts